KLA Announces Upcoming Investor Webcasts
Get Alerts KLAC Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 0.5%
Revenue Growth %: +22.4%
Join SI Premium – FREE
MILPITAS, Calif., May 20, 2021 /PRNewswire/ -- KLA Corporation (NASDAQ: KLAC) today announced webcasts for upcoming virtual investor conferences:
- Wednesday, May 26, 2021 – J.P. Morgan 49th Annual Global Technology, Media and Communications Conference at 2:55 p.m. PT
- Tuesday, June 8, 2021 – Evercore ISI Inaugural TMT Conference at 11:45 a.m. PT
- Wednesday, June 9, 2021 – UBS Global Industrials and Transportation Virtual Conference at 12:00 p.m. PT
- Wednesday, June 16, 2021 – Nasdaq 44th Investor Conference at 8:30 a.m. PT
The live webcast will be available on the Investor Relations page of KLA's website at http://ir.kla.com/ and a replay of the webcast will be posted after the event.
Logo: https://mma.prnewswire.com/media/806571/KLA_Corporation_Logo.jpg
About KLA:KLA Corporation ("KLA") develops industry-leading equipment and services that enable innovation throughout the electronics industry. We provide advanced process control and process-enabling solutions for manufacturing wafers and reticles, integrated circuits, packaging, printed circuit boards and flat panel displays. In close collaboration with leading customers across the globe, our expert teams of physicists, engineers, data scientists and problem-solvers design solutions that move the world forward. Investors and others should note that KLA announces material financial information including SEC filings, press releases, public earnings calls and conference webcasts using an investor relations website (ir.kla.com). Additional information may be found at: www.kla.com (KLAC-F).
View original content:http://www.prnewswire.com/news-releases/kla-announces-upcoming-investor-webcasts-301295522.html
SOURCE KLA Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Accelevation launches IPO roadshow, targets Nasdaq listing
- Palisade Bio gets FDA clearance for Crohn's disease drug trial
- Lianhe Sowell signs deal with Chery Group subsidiary for auto equipment
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
UBS, JPMorgan, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share